Frank O'Donnell

BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Hopkins Capital Group(Hopkins Capital) is a private equity firm founded in 1999 by Frank E. O'Donnell. The firm is headquartered in Tampa, Florida.

Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL.

RetinaPharma Technologies, Inc. is a development stage biotechnology company. Its mission is to become a world leader in the prevention, diagnosis and treatment of neurologically based conditions of the retina, brain, spinal cord and peripheral nerves by offering clinically beneficial and incrementally superior drug carriers, pharmaceuticals and related devices based upon its intellectual property and proprietary technology.

Biotech Specialty Partners LLC specializes in pharmacy and biotechnology. The private company is based in Tampa, FL. The company was founded by Frank E. O'Donnell.

BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL.

Photovision Pharmaceuticals, Inc. provides life sciences technology services. It offers medical instrument products. It focuses on drug development of deprenyl-based propargylamines and drug delivery carriers. The company is located in Rydal, PA.